When most people hear “infertility,” they instinctively picture a women’s health issue. It’s not malicious, it’s just the cultural default. The problem is that it’s also wildly incomplete. In this episode, Dr. Michael Eisenberg makes the case that male reproductive health belongs in the same category as blood pressure, fasting glucose, and cholesterol.
Not because it’s trendy, but because the data keeps pointing in the same direction: semen quality tracks with overall health, and sometimes it seems to predict future health problems.
And that changes the whole story.
Instead of thinking, “I’ll worry about fertility if we can’t get pregnant,” a better frame is: “My reproductive health is part of my health.” If you plan to have kids, it can influence your odds of conceiving, staying pregnant, and having a healthy child. Even if you don’t plan to have kids, it can still act like an early warning light on the dashboard.
So let’s walk through the most important ideas from the conversation, and the practical takeaways that actually matter.
First, what does “male infertility” even mean?
Male infertility isn’t technically defined at the level of the man. It’s defined at the level of the couple.
Clinically, infertility means trying to conceive for one year without pregnancy. Only then do we start asking: is this primarily a female factor, a male factor, or both? That framing matters, because in practice the evaluation often begins with the woman and sometimes never fully shifts to the man.
That’s a mistake. Male fertility is measurable. And in many cases, it’s actionable.
The starting point is usually a semen analysis. Think of it as a reproductive vital sign. It doesn’t answer every question, but it provides a structured look at how well the system is functioning.
A standard test evaluates several key parameters:
- Volume reflects how much seminal fluid is produced. Low volume can signal issues with hormone signaling, the prostate or seminal vesicles, or partial obstruction.
- Concentration (sperm count) measures how many sperm are present per milliliter. Fewer sperm lower the statistical odds of fertilization, though conception can still occur across a wide range.
- Motility assesses how many sperm are actually moving, and ideally moving forward. Movement matters because sperm must navigate the female reproductive tract to reach the egg.
- Morphology evaluates shape. Abnormal structure can interfere with fertilization, particularly if defects affect the head or tail.
And in more advanced testing, DNA fragmentation measures the integrity of the genetic material inside the sperm. Even if count and motility appear adequate, elevated DNA fragmentation can impair embryo development or increase miscarriage risk. It often reflects oxidative stress, metabolic dysfunction, age, or environmental strain.
The bigger point is that semen quality doesn’t just reflect the ability to conceive. It correlates with overall health. Men with metabolic disease, hypertension, obesity, and other comorbidities tend to have lower semen quality.
So a semen analysis isn’t just about answering, “Can I get someone pregnant?”
It’s also quietly answering, “How well is my body functioning?”
Your health shows up in your sperm
Men with more medical problems and more medications tend to have lower semen quality.
Think of reproduction as a “luxury function.” When the body is under strain, it prioritizes survival. Sperm production requires energy, hormonal precision, and a tightly regulated testicular environment. If those systems are disrupted, reproductive output is one of the first places you’ll see it.
At the cellular level, this makes sense. Inflammation from obesity, varicocele, chronic infections, toxin exposure, or even sustained psychological stress can damage Sertoli and Leydig cells inside the testes. That disrupts testosterone signaling, increases oxidative stress, and compromises the environment where sperm are produced. The downstream effects show up on a semen analysis: lower counts, impaired motility, abnormal morphology, and increased DNA damage.
In a large Japanese study comparing over 3,000 infertile men with fertile controls, medical comorbidities were significantly more common in the infertile group. More importantly, when those comorbidities were treated, total motile sperm count improved, both compared to baseline and compared to men whose conditions remained untreated.
In other words: improve health, improve sperm.
Obesity is one of the clearest examples. Across more than 13,000 men in pooled analyses, researchers found a J-shaped relationship between body mass index and severe sperm impairment. As BMI rises into the obese and morbidly obese ranges, the odds of oligospermia (low sperm count) or azoospermia (no sperm) increase substantially, with the highest risk seen in morbid obesity.
So if semen parameters can reflect inflammation, metabolic strain, and systemic dysfunction before overt disease appears, the real question becomes: Why are we waiting until couples have struggled for a year before we look?
Sperm may be telling the story long before anyone is listening.
GLP-1 drugs: what we know so far
GLP-1 medications have moved rapidly from diabetes management to large-scale weight loss tools. That shift matters, because we’re no longer talking about a relatively narrow population of patients, we’re talking about millions of men in their reproductive years.
So what do we know about GLP-1 drugs and male fertility?
When someone with obesity loses weight and maintains the weight loss (whether through continued calorie restriction or GLP-1 use), their sperm parameters tend to improve. The fertility benefit is probably driven primarily by improved metabolic health and reduced adiposity, not by a direct pharmacologic enhancement of sperm production.
That fits with what we understand about obesity and sperm biology. Excess adiposity increases inflammation, oxidative stress, and aromatase activity (converting testosterone to estrogen), all of which can impair spermatogenesis. If GLP-1 therapy helps reverse that metabolic strain, you would expect sperm parameters to improve.
Mechanistically, the picture is intriguing. GLP-1 receptors are present in male reproductive tissues. Preclinical studies in obese and diabetic rodent models suggest that GLP-1 receptor agonists may enhance spermatogenesis, improve hormone profiles, and support sperm function through intracellular pathways like cAMP/PKA and PI3K/Akt signaling. In vitro work has also shown improvements in sperm motility and Sertoli cell metabolism with GLP-1 exposure.
Human data are still limited, but early clinical studies suggest potential improvements in semen parameters and testosterone levels in obese, hypogonadal men. That’s promising, but it’s not definitive.
And this is where Dr. Eisenberg’s broader point comes in.
When a medication scales to enormous populations, the questions have to expand. “Does it help weight loss?” is one endpoint. “Does it improve short-term semen parameters?” is another. But reproductive medicine forces us to ask a longer-term question: What are the generational effects?
We are only beginning to study paternal medication exposure in a serious way. As GLP-1 therapies become more common among younger men, careful evaluation of offspring outcomes will be essential.
Right now, the signal appears encouraging, but large-scale, long-term reproductive data are still catching up to the speed of clinical adoption.
Testosterone and anabolic agents: fertility is the tradeoff people ignore
Exogenous testosterone suppresses sperm production. This isn’t controversial. Testosterone has been studied as a male contraceptive. When you introduce testosterone from the outside — injections, gels, pellets, oral agents — your brain senses that levels are sufficient. It reduces luteinizing hormone (LH) and follicle-stimulating hormone (FSH), the signals that tell the testes to produce both testosterone and sperm.
In simple terms: the factory slows down because the warehouse looks full.
Is it a perfect contraceptive? No. But is it compatible with actively trying to conceive? Also no.
The good news is that recovery is not only possible, it’s predictable for most men.
- About 67% of men regain normal sperm counts within 6 months
- 90% by 12 months
- 96% by 16 months
- And essentially all recover by 24 months
Even men who have been on testosterone replacement therapy (TRT) for years typically recover. The key word is typically. The longer the exposure, the less certain “back to baseline” becomes, and recovery is never instant. It takes full spermatogenesis cycles (2–3 months each) to rebuild.
So what if a man has low testosterone symptoms and wants treatment, but also wants children?
There are alternatives.
One commonly used option in fertility settings is clomiphene citrate. Unlike TRT, clomiphene works upstream. It stimulates the pituitary to release more LH and FSH, which increases the body’s own testosterone production while preserving (or enhancing) sperm production.
The clinical data are reassuring. In symptomatic men, low-dose clomiphene has been shown to roughly double testosterone levels within a few months, with improvements in libido and mood. A large meta-analysis found testosterone increases of approximately 2.6-fold, along with healthy increases in LH and FSH. Long-term follow-up (up to seven years) shows most men maintain normal testosterone with minimal side effects.
When directly compared to TRT, clomiphene produces slightly lower peak testosterone levels, but similar improvements in well-being — without shutting down fertility.
Other fertility-preserving options may include hCG or aromatase inhibitors, depending on the hormonal profile.
And then there’s the practical insurance policy: sperm cryopreservation. If a man plans to start testosterone or anabolic agents and knows children are in his future, freezing sperm beforehand is often a wise move.
None of this means testosterone therapy is “bad.” For many men, it’s appropriate and life-changing. But it’s not neutral when it comes to fertility.
The mistake isn’t using testosterone. The mistake is using it without understanding the tradeoff.
Environmental exposures: microplastics are in the testicles now
Microplastics have been detected in testicular tissue. They’ve been found in semen. We are no longer debating whether exposure exists, we’re debating what it means.
Several studies , including emerging human data, have linked higher concentrations of microplastics in semen with poorer semen parameters, including reduced motility and lower sperm counts. Do we fully understand the clinical implications yet? No. But we’re well past the point of pretending this is a fringe issue.
And microplastics are only part of the story.
Sperm are uniquely vulnerable to environmental toxicants. Substances like plastic additives, PFAS (“forever chemicals”), flame retardants, surfactants, and pesticides can accumulate in reproductive tissues. Men with infertility often show higher concentrations of certain toxicants in their semen compared to fertile controls, and semen quality declines as xenoestrogen levels increase (compounds that mimic estrogen and disrupt hormonal signaling).
Pesticides are another concern. A presentation at the 2024 ASRM Scientific Congress reported that men with higher dietary intake of pesticide residues from fruits and vegetables had lower fertilization rates during fertility treatment, and these exposure levels were still within current regulatory “safe” limits. That’s what makes this complicated. “Safe” for general toxicity may not be neutral for sperm function.
A broader systematic review of dozens of studies found consistent associations between pesticide exposure and reduced sperm count, motility, morphology, and increased DNA fragmentation. Organophosphates, organochlorines, and even widely used household pyrethroids have been implicated in genetic damage and chromosomal abnormalities in sperm.
Mechanistically, this aligns with what we see in laboratory models. Micro- and nanoplastics, along with endocrine-disrupting chemicals, appear capable of degrading the blood–testis barrier, disrupting hormone synthesis pathways, inducing oxidative stress, and damaging Sertoli and Leydig cells — the very cells responsible for nurturing sperm and producing testosterone. Most of this mechanistic data comes from animal and in vitro studies, so translating it directly to humans requires caution. But the biological plausibility is strong.
But the reality is that plastic and chemical exposures are now ubiquitous. They’re in food systems, packaging, clothing, water, and air. It’s unrealistic to live as if complete avoidance is possible. Control what you reasonably can:
- Don’t microwave food in plastic.
- Reduce reliance on plastic water bottles.
- Wash produce thoroughly; consider organic options for high-residue crops when feasible.
- Minimize unnecessary chemical exposures in the home when possible.
These aren’t extreme interventions. They’re incremental reductions in avoidable exposure.
The science is still evolving. Measurement tools are improving. Human longitudinal data are still catching up. But the direction of evidence is consistent: sperm health is sensitive to environmental load.
And when a biological system is this sensitive, small reductions in exposure may matter more than we assume.
Heat exposure: saunas and hot tubs are not “neutral” for sperm
Sperm production is temperature-sensitive for a reason. The testes sit outside the body because they need to stay cooler than core temperature to function optimally. The ideal range for spermatogenesis is roughly 34–35°C (93–95°F) — about 2–3°C lower than normal body temperature.
The scrotum regulates this through subtle but constant adjustments: relaxing or contracting to change proximity to the body, increasing surface area, even leveraging evaporative cooling through perspiration. It’s a finely tuned system.
When testicular temperature rises above that optimal range, sperm production can decline. Morphology can worsen. Motility can drop. And because sperm production takes about two to three months, a single sustained period of heat exposure can blunt output for an entire cycle.
This is where lifestyle collides with timing.
Hot tubs and saunas are popular for cardiovascular health and longevity. But prolonged exposure to elevated temperatures has been consistently associated with reduced sperm counts and impaired motility. The same goes for everyday heat exposures people rarely think about: laptops placed directly on the lap, heated car seats during long commutes, tight or non-breathable underwear that traps warmth.
Does this mean no man should ever use a sauna? No. Context matters.
But if you’re actively trying to conceive in the next few months, heat exposure becomes a lever you can pull immediately. This isn’t a forever rule. It’s a strategic adjustment during a fertility window.
Marijuana: mixed data, but the clinical stance is cautious
Cannabis use is increasing, particularly among younger men. And when something becomes culturally normal, it’s easy to
assume it’s biologically neutral. It isn’t.
The strongest evidence linking cannabis to male fertility concerns semen parameters. Across multiple studies , frequent use, especially daily use, has been associated with lower sperm count and concentration, impaired motility, abnormal morphology, and reduced viability. Some data suggest cannabis may also interfere with capacitation, the process sperm undergo to become capable of fertilizing an egg.
Animal models go further, showing associations with testicular atrophy and reduced libido. Those findings haven’t been cleanly replicated in humans, but they reinforce a consistent theme: the endocannabinoid system interacts with reproductive biology in meaningful ways.
Hormonal data are less clear. Some studies show lower luteinizing hormone (LH), others show minimal or inconsistent effects on testosterone, and follicle-stimulating hormone (FSH) often appears unchanged. That variability makes the endocrine story more complicated than a simple “it lowers testosterone” narrative.
There’s also a behavioral confounder to acknowledge. Heavy cannabis users are statistically more likely to smoke tobacco, use other substances, have irregular sleep patterns, or maintain poorer dietary habits, all of which independently affect semen quality. Untangling cannabis from the lifestyle context is difficult.
That’s why the data are described as mixed.
But clinically, the stance tends to be straightforward: cannabis is unlikely to improve fertility, and frequent use may impair it. If a couple is actively trying to conceive, reducing or eliminating daily use is a low-risk, potentially high-upside adjustment.
When sperm quality is already sensitive to metabolic stress, inflammation, and toxin exposure, adding another variable with documented reproductive effects is probably not a strategic move, at least not during a conception window.
Exercise: better is good… until “too much” isn’t
Physical activity is one of the most consistent lifestyle levers for improving sperm health.
Moderate-to-vigorous exercise has been associated with higher sperm concentration, and the benefits appear dose-responsive up to a point. In some cohorts, men performing more than seven hours per week of structured exercise had the best semen parameters. Specific activities such as two or more hours of weight training per week, or regular outdoor activity, have been linked to improved sperm concentration.
When resistance and endurance training are combined, the benefits seem to extend beyond count alone. A meta-analysis of controlled studies found improvements in semen quality along with reductions in oxidative stress and inflammatory markers within seminal fluid. That makes physiological sense. Exercise improves insulin sensitivity, reduces systemic inflammation, enhances mitochondrial function, and supports hormonal balance, all of which influence the testicular environment.
But like many biological systems, fertility responds to stress on a curve.
Push too little, and the system stagnates. Push too hard, and the body begins reallocating resources. Extremely high training volumes, chronic exhaustion, very low body fat, and insufficient recovery can shift the body toward survival mode rather than reproduction. The result isn’t usually a dramatic collapse. It’s more subtle: sperm parameters that are “great” drift toward “slightly less great.”
In population terms, that might not matter. In the narrow window of trying to conceive, it can.
One interesting nuance is cycling. More than about 1.5 hours per week of cycling is associated with lower sperm quality, possibly due to a combination of heat exposure and prolonged perineal pressure. That doesn’t mean no one should ever ride a bike, just train intelligently.
Lift weights. Move regularly. Build muscle. Support metabolic health. But respect recovery, avoid chronic exhaustion, and recognize that reproductive physiology thrives in a body that feels safe, not one perpetually redlined.
Varicocele: a common, fixable cause that gets missed
Varicoceles are dilated veins in the scrotum, and they are one of the most common correctable causes of male infertility.
The physiology is straightforward. The testes sit outside the body to maintain a temperature a few degrees below core body temperature. Enlarged veins can impair that cooling system, allowing blood to pool and raising local temperature. Over time, that subtle thermal stress can disrupt spermatogenesis, increase oxidative stress, and impair sperm production.
Varicoceles are present in a substantial proportion of infertile men. And importantly, they are treatable.
Across pooled analyses involving over 1,300 patients, varicocele treatment — whether surgical or radiologic — has been associated with improved pregnancy rates and significant increases in sperm concentration compared with observation alone. On average, sperm concentration improved by more than 12 million per milliliter. In men with abnormal semen parameters at baseline, the benefits are particularly evident. While improvements in morphology and progressive motility are less consistent when compared directly to observation, within treated groups those parameters often improve relative to baseline.
The frustrating part isn’t whether varicoceles matter. It’s timing.
Sperm production takes roughly two to three months. After varicocele repair, improvements in semen quality may take three to six months to fully manifest. When a couple has already been trying for a year, that timeline can feel unbearably slow. This delay is one reason male-centered fertility trials are hard to enroll in, because couples often want immediate intervention rather than incremental improvement.
But that’s precisely why early evaluation matters. If varicocele is identified sooner, before months or years of unsuccessful attempts, it becomes a strategic opportunity rather than a last resort.
PRP injections into the testes
This is not standard of care. It’s experimental. And it’s being used selectively.
Platelet-rich plasma (PRP) is derived from a patient’s own blood and concentrated to contain higher levels of growth factors and signaling molecules. It’s already used in orthopedics, dermatology, and sports medicine to support tissue repair. The question is whether those same regenerative properties can help the testes in specific cases of male infertility.
Dr. Eisenberg described using intratesticular PRP in a narrow population: men with non-obstructive azoospermia who had already undergone testicular sperm extraction and no sperm were found. In other words, men who had effectively been told that biological fatherhood was unlikely.
In that group, about 20% had sperm detected after a subsequent sperm cycle following PRP injection. For those men, the that’s the difference between “no biological child possible” and “IVF is now an option.”
Beyond this small but meaningful signal, broader research is beginning to explore PRP’s role in male reproduction. In vitro studies suggest that adding PRP or related growth factor preparations to culture media may improve sperm viability and cellular proliferation. Incorporating PRP into incubation or cryopreservation protocols has been associated with improved motility and structural integrity of sperm.
In vivo studies indicate that intratesticular PRP may support improvements in sperm parameters, hormone balance, and even testicular tissue architecture. Mechanistically, PRP appears to exert antioxidative and tissue-reparative effects and may reduce testicular toxicity or ischemia-related injury.
But caution is warranted.
Most of the data remain preliminary. Study populations are small. Protocols vary. Long-term outcomes are still being defined. This is not a first-line therapy for the average man with mild sperm abnormalities.
What it represents, though, is proof of concept.
For decades, male infertility care has focused on hormonal manipulation or mechanical sperm retrieval. Regenerative approaches suggest a different future, one where the testicular environment itself may be modifiable.
The takeaway that keeps coming back: men should be evaluated earlier
One of the most striking realities in this entire conversation is how often men are left out of their own fertility story. Even among couples pursuing fertility treatment, a quarter to a third of men are never formally evaluated.
If semen quality is measurable, dynamic, and in many cases modifiable, then delaying male evaluation wastes time. And in fertility, time is not neutral. Months matter. Age matters. Biological windows matter.
But this isn’t only about pregnancy.
Semen parameters reflect metabolic health, inflammatory burden, hormonal balance, and vascular integrity. In some studies, abnormal semen quality precedes the development of conditions like diabetes. That reframes male fertility testing as more than a reproductive screen. It becomes a potential early-warning system.
Early evaluation creates options.
- If there’s a varicocele, it can be repaired before years pass.
- If there’s a hormonal imbalance, it can be addressed.
- If lifestyle is impairing sperm production, there’s time to intervene.
- If exogenous testosterone is suppressing sperm, that can be corrected before it becomes urgent.
And psychologically, it shifts the posture. Instead of waiting passively while their partner undergoes invasive testing and treatment, men can participate actively. They can change inputs. They can improve health. They can gather data.
Fertility may be a team sport. But teams function best when both players are on the field.
Action Checklist: The Male Fertility “Basics + Big Levers” Plan
If you want a practical plan you can actually follow, start here.
1) Get the data early
- Get a semen analysis (don’t wait a year if you’re concerned).
- If there are abnormalities, repeat it after a full sperm cycle (~2–3 months) because sperm is dynamic.
- Consider advanced testing (like DNA fragmentation) if you’ve had miscarriages, failed IVF, or unexplained infertility.
2) Treat fertility like metabolic health
- Get screened for blood pressure, fasting glucose/A1c, lipids, and obesity-related issues.
- If you already have comorbidities (hypertension, diabetes, etc.), treat them aggressively and thoughtfully.
3) Audit medications with a fertility lens
- If trying to conceive: discuss exogenous testosterone/anabolics with your clinician (it can suppress sperm production).
- If on metformin: discuss timing, indication, and options if conception is near-term.
- Review finasteride, alpha blockers (like tamsulosin), and any long-term medications with a clinician who understands fertility.
- Don’t stop essential meds impulsively, but don’t ignore this category either.
4) Stop cooking the testes
- Avoid hot tubs and saunas when actively trying to conceive.
- Avoid prolonged heat exposure (including laptops directly on the lap).
- If you’ve had a high fever/illness recently, remember sperm may temporarily drop for a full cycle and then recover.
5) Sleep like it matters
- Aim ~7–9 hours consistently.
- If you snore, wake unrefreshed, or feel daytime fatigue: consider sleep apnea evaluation.
6) Exercise, but don’t live in overtraining
- Train consistently.
- Avoid chronic exhaustion patterns (high volume + poor recovery + low body fat + poor sleep).
- Think “athletic and resilient,” not “surviving on stimulants and willpower.”
7) Reduce obvious toxicant exposures
- Don’t microwave plastics.
- Reduce plastic bottle use where realistic.
- Make simple swaps that lower avoidable exposure without trying to live in a bubble.
8) If you’re using marijuana frequently
- Consider reducing or pausing while trying to conceive, especially if use is daily or heavy.
9) If conception is the goal, time sex strategically
- In general, every other day around the fertile window is a practical approach (sperm can live ~2 days in the female tract).
- Avoid multiple ejaculations per day during the window (it can reduce “payload delivery”).
- If abstinent for a long time, consider “clearing the pipe” before timing matters.
10) Know when to escalate
- If semen parameters are abnormal, ask about evaluation for varicocele and hormone testing.
- If azoospermia is present, ask about next-step diagnostics and options (including extraction, and emerging approaches in appropriate cases).
- If you’re going to use testosterone/anabolics long-term and might want kids later: consider sperm freezing as an insurance policy.
